Zenoti is widely used by spas, salons, and medspas for managing appointments, marketing, and client communication. Its all-in-one approach makes it appealing for businesses that want to streamline operations. However, for medspas offering GLP-1 medications, telehealth services, or prescription shipping, Zenoti’s payment solution often falls short.
Behind the scenes, Zenoti’s payment processing relies on Stripe. While Stripe works well for low-risk industries, it does not permit transactions involving prescription drugs, compounded products, or medically supervised weight loss programs. This creates a major risk for clinics operating in these areas.
We regularly speak with medspas that had their accounts frozen or terminated without notice. In many cases, these were fast-growing, fully licensed businesses that simply didn’t realize their payment processor could not support what they offer.
Corepay is a better alternative for medspas with more advanced compliance needs. We provide high-risk merchant accounts tailored to GLP-1 providers, telehealth models, and clinics working with regulated products. Our solutions are designed to protect your business as you grow, with the infrastructure and support that platforms like Zenoti cannot offer.
Why Zenoti Payments Fall Short for GLP-1 and Telehealth Clinics
Zenoti was built for spa and beauty businesses. It was not designed to handle regulated healthcare transactions or prescription fulfillment. If you’re using Zenoti to manage both front-end booking and backend billing, and your clinic provides prescription-based care, you may already be at risk.
Stripe, the processor behind Zenoti’s payment system, prohibits:
- Online sales of GLP-1s like semaglutide and tirzepatide
- Compounded medication sales
- Telehealth consultations tied to prescriptions
- Cross-state or pharmacy-involved fulfillment workflows
These restrictions mean that even compliant, well-structured clinics can be flagged or shut down once Stripe detects certain keywords, prescription products, or billing behavior. There is often no opportunity to appeal or correct the issue.
Corepay Is Built For High–Risk Payments Such As GLP1-1 Treatments
Corepay provides high-risk merchant accounts for businesses that operate outside of what traditional platforms support. We specialize in helping clinics that offer regulated products, prescription therapies, and telehealth models to accept payments safely and stay compliant.
We work directly with acquiring banks that understand GLP-1 treatments and offer the flexibility needed to serve patients both in person and online.
Corepay benefits include:
- Support for GLP-1, peptides, and compounded therapies
- Access to domestic and offshore banks comfortable with high-risk models
- Merchant category code (MCC) assignments that reflect your real business model
- Assistance with LegitScript certification
- Real-time fraud and dispute monitoring
- Built-in support for VAMP compliance and chargeback mitigation tools
If your medspa has plans to grow into multi-state care, telehealth, or e-commerce fulfillment, our infrastructure is built to support that from the start.
Zenoti vs Corepay: A Direct Comparison
| Feature | Zenoti | Corepay |
|---|---|---|
| GLP-1 and semaglutide payments | Not allowed | Supported |
| Telehealth models | Not allowed | Supported |
| MCC customization | No | Yes |
| LegitScript onboarding | No | Yes |
| Chargeback support | None | CB-Alert, RDR, CDRN |
| Visa VAMP tracking | Not supported | Actively managed |
| Payment gateway | Stripe | Netvalve (Corepay’s proprietary gateway) |
What We See On A Weekly Basis
We’ve helped many clinics recover after being flagged by Stripe or similar processors. One common situation involves a medspa that adds semaglutide injections to its service lineup and begins accepting payments through Zenoti. Everything works smoothly until a fraud report or keyword scan triggers a red flag.
From there, the account is frozen. Payouts are stopped. And because Stripe classifies the activity as prohibited, there is often no clear process to reinstate payments.
Corepay prevents this outcome by working with banks that already accept GLP-1 services. We structure merchant accounts to reflect your actual services, apply the correct MCC, and help you stay under key thresholds such as Visa’s VAMP dispute ratios.
Transitioning from Zenoti to Corepay: What to Expect
Switching from Zenoti’s built-in payments to Corepay is easier than most clinics realize. We work with you to set up a compliant processing environment without disrupting your client workflow.
Step 1: Apply with Corepay
Submit your business details, including licensing, offerings, and volume projections. We will assess your eligibility for placement with our banking partners.
Step 2: Get matched with the right acquiring bank
We work with both US and international banks that understand GLP-1 and high-risk healthcare models.
Step 3: Integrate with Netvalve
Our in-house gateway supports e-commerce, subscription billing, invoicing, and fraud controls. We also offer real-time reporting and tokenization for recurring patients.
Step 4: Stay protected as you scale
Once approved, your business can process payments with the tools, visibility, and stability needed to grow confidently.
Final Thoughts
Zenoti is a useful platform for client experience and spa operations, but it was not built for medspas that sell GLP-1s, ship prescriptions, or operate in regulated healthcare.
If your business falls into one of these categories, continuing to rely on Zenoti’s Stripe-powered payments puts your account and revenue at risk.
Corepay is the best alternative to Zenoti for medspas offering prescription-based weight loss programs and telehealth services. Our high-risk merchant accounts are designed for long-term stability, regulatory alignment, and full support for modern medspa models.
